That's important, due to the fact that the method a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work. To put it simply, we need to understand how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error process (toxic tech 5 tech darlings). However now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're created to do. This was an advancement practically nobody noticed. However it's going to have profound ramifications for treating illness. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be a lot of investment opportunities in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (the legacy report prediction). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it pulled back possibly considerably before going higher - jeff brown latest prediction. I've been covering bitcoin for a very long time now. One of the first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were primarily informing readers. But that's not the big concern anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a relied on 170-year-old organization. So believe about that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. jeff brown prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are many fantastic personal business on the verge of striking the general public markets And I've been working on a new method for you to invest even before these business go public.
This opportunity has actually been developing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the information. Go right here to reserve your area totally free.
Emma Walsh here, handling editor of the Journal. Routine Journal readers know that tech isn't our typical beat (jeff brown predictions 2021). And when it pertains to tech investing, we leave it to the specialists. Fortunately, we have numerous such professionals in our Rolodex. Our colleague Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing professionals we know (white house). In reality, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge picture and forecast what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These trends are experiencing exponential growth and creating amazing chances for financiers. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. jeff brown stock market prediction. But despite what many readers might believe, this is a trend that's just getting going. Although the COVID-19 pandemic interrupted supply chains last year, an outstanding 250 million 5G-enabled gadgets were still offered.
And all of this eventually led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown). Losing 2 months of production and sales actually affects the number of 5G gadgets are offered in the calendar year. When you think about all of that, selling 250 million units is remarkable. More notably, the hold-ups triggered by the pandemic produced a load of bottled-up need. Which demand is now going to be pressed into 2021. In truth, I forecast that more than 500 million 5G gadgets will be shipped in 2021 - legacy report prediction. And that's not my only 5G forecast When I've talked about 5G in the past, I have actually explained its three different phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Phase 3, 5G services start to be provided (jeff brown biotech pick). That's when we start to see applications operating on 5G networks. Think of things like massive multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Stage Three by this summertime. This starts something of a virtuous cycle: Many people don't really appreciate the technology. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In fact, 5G is going to open up a suite of incredible applications: self-driving vehicles, the Internet of Things, robotic surgical treatment, and more. All of these innovations need 5G. The investment chances going forward will be enormous. Stepping away from 5G, the next crucial innovation I visualize in 2021 is CRISPR genetic editing. CRISPR represents "clustered frequently interspaced brief palindromic repeat." It's a mouthful. However it is among the most amazing developments in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software application.
The program can crash or not work correctly. CRISPR utilizes a comparable concept however with our hereditary code. "Typos" in our genome can cause illness. CRISPR can remedy these "typos." For years, CRISPR was mainly a specific niche innovation that wasn't well comprehended. And during that time, there were truly only 3 companies running in this space. However things are altering. CRISPR is no longer just theoretical. We're seeing real outcomes. We're dealing with diseases and seeing that this innovation simply works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and providing amazing returns. This entire industry is effectively a greenfield opportunity.
There's room for lots of business to exist in this area. what is the legacy report predicting. And there will be more. That's my forecast for CRISPR in 2021. I forecast that 2 or three more hereditary modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing incredible things happening at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software application can properly anticipate the folding of a protein based entirely on its amino acid sequence with 92. 4% accuracy. That is very important due to the fact that the method a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and be effective.
Historically, this has been a trial-and-error process. Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to create drugs that do what they're created to do. And here's my next forecast. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one however a number of drug treatments produced using this technology. This was among those advancements that nearly no one observed. But it's going to have profound ramifications for curing illness. And, obviously, there will be plenty of investment chances in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back maybe considerably prior to going higher. I have actually been covering bitcoin for a very long time now. One of the very first research reports I ever published was on bitcoin - longtime readers. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. But at the time of that initial recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
However nobody is asking that concern any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. black sea. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the info is up to date as of February 2021, however we might not separately validate this claim. Given Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like ability to pick winning innovation stocks. He invested more than 25 years looking into innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an outstanding viewpoint on the market. He's constantly on the hunt for brand-new chances, and he shares a lot of his best picks in the Future Report.
That's high appreciation, however it's not absurdly reasoned. Brown has an exceptional credibility as a stock-picker, and he successfully forecasted a few of the most significant financial occasions of the previous 20 years. Although he does not appear to release his choices to the public, the service's success is a direct indication of Brown's stock-picking prowess. Nobody on Wall Street gets it right each time, however Jeff Brown's precise predictions have earned him legions of devoted followers. That states a lot about his ability. The Near Future Report is released by Brownstone Research, a prominent financial research study publisher. Brownstone Research study provides a number of research services with a variety of specializations - diplomatic relations.
The business is likewise affiliated with Bonner & Partners, another well-respected research study publisher - first lady. On its website, Brownstone says its objective is to supply retail investors with professional-grade research: "For too long, the best investment research has actually not been available to individual investors. It has actually been typically scheduled for investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown stock predictions 2021. The mission of Brownstone Research is to make that type of proprietary research readily available to any financiers aiming to gain an edge in the marketplaces. The goal is simple to deliver special and rewarding financial investment research found no place else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise acts as the company's Chief Financial investment Expert.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to offer its clients. After years of constant success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout many of America. If you know even a little bit about the market, you understand that he has a credibility as a King Midas of sorts. jeff brown genome sequencing. Everything he touches turns to gold! Jeff is well conscious of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In reality, Brown thinks S.A.V. jeff brown genome sequencing. might be "the greatest trend of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying two innovative innovations: synthetic intelligence and electric automobiles. Musk hopes the combination will assist him establish the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing short of the vehicle industry's Holy Grail. As you know, electric vehicles and self-driving cars and truck stocks have been huge this year, however the Wall Street machine has actually approved buzz without much tangible outcome. Regardless of a drastic increase in competitors over the previous couple of years, Brown still thinks Musk has the finest possibility of putting all of it together.
tech could be the magic string that ties everything together. S.A.V. stands for Shared Autonomous Vehicle, and it might be the future of transportation. Generally, this technology would enable you to rent your car as an autonomous, self-driving taxi when you're not using it. You simply leave the car and press a button on an app that tells the vehicle to "join the fleet." Next thing you know, you're unwinding on your couch while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a significant chunk of the profits. It sounds ridiculous, however it might be closed than you think.